CN102688262A - Nutritional health-care product for improving depression - Google Patents
Nutritional health-care product for improving depression Download PDFInfo
- Publication number
- CN102688262A CN102688262A CN2012101899896A CN201210189989A CN102688262A CN 102688262 A CN102688262 A CN 102688262A CN 2012101899896 A CN2012101899896 A CN 2012101899896A CN 201210189989 A CN201210189989 A CN 201210189989A CN 102688262 A CN102688262 A CN 102688262A
- Authority
- CN
- China
- Prior art keywords
- depression
- improving
- health
- care product
- nutritional health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the technical field of health-care drugs and foods, in particular to a nutritional health-care product for improving depression. The nutritional health-care product for improving the depression comprises phosphatidyl choline, phosphatidylserine, Japanese strobus pine extract and lycine in certain proportion. The nutritional health-care product for improving the depression is capable of effectively improving symptoms, such as mental function, mood condition, behavioral expression and the depression, enhancing and promoting memory, stimulating mental power, relieving pressure and supplying vigor and effectively relieving the depression and memory deterioration through regulating a brain and nervous system and a secretory system by adopting all natural components, does not contain any Western medicine components, does not generate physical dependence or toxic and side effects on human bodies, can be taken for a long time and can be used for effectively preventing the depression from repeatedly attacking.
Description
Technical field
The present invention relates to the health medicine food technology field, refer in particular to a kind of nutrient and healthcare products that improve depression.
Background technology
Depression is a kind of common mood disorders, can be caused by a variety of causes, is to be one type of mental illness of principal character with depressed, and the light-duty patient's appearance of its clinical manifestation is as usual, and heart has painful experience.That heavy slightly people can show as is depressed, have a worried look, moan and groan, feel oneself inferior etc., and some patient is usually with the neurosis symptom, as absent minded, hypomnesis, delay of response and, symptom such as insomnia and dreamful sleep.That heavy patients with depression can occur is pessimistic and worldweary, desperate, oneself crime of self-accusation, hallucination vain hope, inappetence, body weight fall sharply, hypofunction and with serious suicidal attempt, even suicide.Human health is constituted a serious threat.
The therapeutic modality of depression comprises Drug therapy, psychotherapy, naturopathy; But most cases have the tendency of outbreak repeatedly; Formation is to the dependence of medicine; Moreover the medicine of much treating depression exists side effect bigger, and patient health is constituted influence, and there be limited evidence currently of has the nutrient and healthcare products to depression.
Summary of the invention
The present invention is directed at present the deficiency to the existence of depression Drug therapy, and a kind of nutrient and healthcare products that improve depression are provided, for realizing above purpose, the present invention adopts following technical scheme:
A method for improving nutritional supplements for depression, the health care per dose composition containing an effective health treatment as follows: phospholipids, choline 30-50mg, phospholipids, serine 35-55mg, five pine extract 75-100mg, Beet Yan 20-60mg.
Preferably, the weight of the respective components as follows: choline phospholipids 40mg, serine phospholipids 47mg, five pine extract 84mg, beet Yan 40mg.
Preferable, said health product are capsule or oral liquid.
The invention has the advantages that: the present invention to improve nutritional supplements for depression, including a certain ratio of the amount of choline phospholipids, phospholipid serine, five pine extract, beet Yan formed, the present invention uses pure natural ingredients, by adjusting the brain and the endocrine system, can effectively improve mental function, mood status, behavior, symptoms of depression, increase and improve memory, mental excitation, relieving stress, rejuvenate, relieve depression and memory loss, no Western medicine, the human body without dependent toxic side effects, long-term use and effectively prevent recurrent episodes of depression.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is further specified:
Embodiment 1:
A method for improving nutritional supplements for depression, the health care per dose composition containing an effective health treatment as follows: phospholipid choline 30mg, phospholipids serine 55mg, five pine extract (preferably Caucasus five pine extract ) 75mg, Beet Yan 60mg.
About the form of health product of the present invention, the present invention does not do concrete restriction, and those skilled in the art add the suitable additive that allows according to basic general knowledge and demand in prescription, can produce capsule, oral liquid or the like.
Embodiment 2:
In this embodiment include another recipe for depression improved nutrition and health care products, health products per dose composition containing an effective health treatment is as follows: the health care products containing per dose effective health treatment composition is as follows: phospholipid choline 50mg, phospholipid serine 35mg, five pine extract 100mg, beet Yan 20mg.
Embodiment 3:
As a preferred embodiment, the present invention is the improvement of depression in the following ratio of the components was better, phospholipids, choline 40mg, serine phospholipids 47mg, five pine extract 84mg, beet Yan 40mg.
The nutrient and healthcare products that improve depression of the present invention are all obtained good curative effect in various degree through a lot of clinical verifications.Enumerate a case wherein at present: Yin so-and-so, the woman, 28 years old because of emotional problem, and life is lost the confidence, melancholy insomnia, menoxenia, she tired forgetful; And the thought of committing suicide is arranged, and being diagnosed as patients with depression, the nutrient and healthcare products that improve depression of the present invention are taken in suggestion, sooner or later obey a dosage, after one month; Mood takes a turn for the better, hypermnesia, and sleep quality improves, to life Is Full confidence; Do not have other uncomfortable reactions, depression disappears basically, adheres to taking always, and depression does not recur at present.
The above embodiment; It is preferred embodiments of the present invention; Be not to limit practical range of the present invention,, all should be included in the patent claim of the present invention so all equivalences of doing according to the described structure of claim of the present invention, characteristic and principle change or modify.
Claims (3)
- A method for improving the nutritional supplements depression, characterized in that said health care products containing an effective dose of each ingredient health treatment as follows: choline phospholipids, 30-50mg, phospholipids, serine 35-55mg, five pine Extract 75-100mg, beet Yan 20-60mg.
- (2) as claimed in claim 1, wherein an improvement of depression nutritional supplements, characterized in that the amount of each component is: choline phospholipids 40mg, serine phospholipids 47mg, 84mg five pine extract beet Yan 40mg.
- 3. a kind of nutrient and healthcare products that improve depression according to claim 1 and 2 is characterized in that said health product are capsule or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101899896A CN102688262A (en) | 2012-06-09 | 2012-06-09 | Nutritional health-care product for improving depression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101899896A CN102688262A (en) | 2012-06-09 | 2012-06-09 | Nutritional health-care product for improving depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102688262A true CN102688262A (en) | 2012-09-26 |
Family
ID=46854107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101899896A Pending CN102688262A (en) | 2012-06-09 | 2012-06-09 | Nutritional health-care product for improving depression |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102688262A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113768913A (en) * | 2021-09-27 | 2021-12-10 | 南京百得生物科技有限公司 | Application of betaine in preparation of medicines, foods and health products for improving ovarian function, medicines, foods, health products and animal models |
-
2012
- 2012-06-09 CN CN2012101899896A patent/CN102688262A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113768913A (en) * | 2021-09-27 | 2021-12-10 | 南京百得生物科技有限公司 | Application of betaine in preparation of medicines, foods and health products for improving ovarian function, medicines, foods, health products and animal models |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bernal-Pacheco et al. | Nonmotor manifestations in Parkinson disease | |
| Golianu et al. | Non-pharmacological techniques for pain management in neonates | |
| Whitmore | Complementary and alternative therapies as treatment approaches for interstitial cystitis | |
| Faryadi | The magnificent effect of magnesium to human health: a critical review | |
| JP5918389B2 (en) | Elazitannin-rich extract composition | |
| Birkmayer et al. | Understanding the Neurotransmitters: Key to the Workings of the Brain | |
| Ahir et al. | Evaluation of clinical effect of Kushmandadi Ghrita in generalized anxiety disorder | |
| CN102688262A (en) | Nutritional health-care product for improving depression | |
| Gulluoglu et al. | Patients in northwestern Turkey prefer herbs as complementary medicine after breast cancer diagnosis | |
| Marshall et al. | Integrative intervention: A new perspective and brief review in aphasia | |
| Lavalle | Relora: The Natural Breakthrough to Losing Stress-Related Fat and Wrinkles | |
| F Perazzo et al. | Double-blind clinical study of a multivitamin and polymineral complex associated with panax ginseng extract (Gerovital®) | |
| Babić et al. | Complementary and alternative medicine in the treatment of schizophrenia | |
| Bongartz et al. | Sleep Promoting Effects of IQP‐AO‐101: A Double‐Blind, Randomized, Placebo‐Controlled Exploratory Trial | |
| Patil et al. | Introduction, Epidemiology, Etiology, and Pathophysiology of Migraine Pain | |
| Smithback et al. | Homeopathy and Supplementation for Anxiety Case Report. | |
| Shah et al. | Appropriate Commencement, Perpetuation, and Abstinence of Commonly Subsumed SSRIs, SNRIs, and TCAs Imperative in the Management of Panic Disorder-An overview | |
| Bosch | Needles on the couch: acupuncture in the treatment of depression, schizophrenia and sleep disorders | |
| Elstein | Saving face (and body) with magnesium | |
| Singh et al. | A CASE STUDY ON BALANCING URTICARIA: AN AYURVEDIC APPROACH TO MANAGEMENT | |
| Rountree | Roundoc Rx: Insomnia: The Impact on Health and Interventions to Improve Sleep | |
| Ross | Insomnia: an integrative approach to stress-induced insomnia | |
| causes Pneumonia | WHO downgrades Tamiflu Suvorexant: A hypnotic causing cataplexy | |
| Yu et al. | Parkinson’s Disease | |
| is Unmasked | Vitamins for Stress| Our 2021 Guide to the Best Anxiety Supplements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120926 |